Evidence map›Paper›PMID 33400831›Full record

ArticleChembiochem : a European journal of chemical biology2021

An Artificial Cofactor Catalyzing the Baylis-Hillman Reaction with Designed Streptavidin as Protein Host*.

Horst Lechner, Vincent R Emann, M Breuning, Birte Höcker

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. An artificial nickel chlorinase based on the biotin-streptavidin technology.Chemical communications (Cambridge, England) · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Streptavidin-Hosted Organocatalytic Aldol Addition.Molecules (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Horst LechnerDepartment of Biochemistry, University Bayreuth, Universitätsstrasse 30, 95447, Bayreuth, Germany.ORCID 0000-0002-2177-2611
Vincent R EmannDepartment of Biochemistry, University Bayreuth, Universitätsstrasse 30, 95447, Bayreuth, Germany.
M BreuningOrganic Chemistry, University Bayreuth, Universitätsstrasse 30, 95447, Bayreuth, Germany.ORCID 0000-0002-2004-4196
Birte HöckerDepartment of Biochemistry, University Bayreuth, Universitätsstrasse 30, 95447, Bayreuth, Germany.ORCID 0000-0002-8250-9462

Funding

Austrian Science Fund J3994 B21Austrian Science Fund FWF J 3994Austrian Science Fund (FWF, Erwin Schrödinger fellowship J3994 B21
6 · The paper itself

Abstract

An artificial cofactor based on an organocatalyst embedded in a protein has been used to conduct the Baylis-Hillman reaction in a buffered system. As protein host, we chose streptavidin, as it can be easily crystallized and thereby supports the design process. The protein host around the cofactor was rationally designed on the basis of high-resolution crystal structures obtained after each variation of the amino acid sequence. Additionally, DFT-calculated intermediates and transition states were used to rationalize the observed activity. Finally, repeated cycles of structure determination and redesign led to a system with an up to one order of magnitude increase in activity over the bare cofactor and to the most active proteinogenic catalyst for the Baylis-Hillman reaction known today.

Indexed as

BiocatalysisDensity Functional TheoryMolecular Dynamics SimulationMutagenesis, Site-DirectedPyridinesStereoisomerismStreptavidin4-(dimethylamine)pyridinePyridinesStreptavidinartificial cofactorsBaylis-Hillman reactionbiocatalysisprotein designstreptavidin

Identifiers

PMID33400831
PMCPMC8247847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.